BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel HP, Gandhi PA, Chaudhari PS, Desai BV, Desai DT, Dedhiya PP, Maulvi FA, Vyas BA. Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies. Journal of Drug Delivery Science and Technology 2021;64:102533. [DOI: 10.1016/j.jddst.2021.102533] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Abdelmonem R, Al-Samadi IEI, El Nashar RM, Jasti BR, El-Nabarawi MA. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation. Drug Deliv 2022;29:2868-82. [PMID: 36065090 DOI: 10.1080/10717544.2022.2115164] [Reference Citation Analysis]
2 Zafar A, Awad Alsaidan O, Alruwaili NK, Sarim Imam S, Yasir M, Saad Alharbi K, Singh L, Muqtader Ahmed M. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation. Int J Pharm 2022;:122232. [PMID: 36155794 DOI: 10.1016/j.ijpharm.2022.122232] [Reference Citation Analysis]
3 Correia AC, Monteiro AR, Silva R, Moreira JN, Sousa Lobo JM, Silva AC. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Adv Drug Deliv Rev 2022;189:114485. [PMID: 35970274 DOI: 10.1016/j.addr.2022.114485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nguyen T, Duong V. Solid Lipid Nanoparticles. Encyclopedia 2022;2:952-73. [DOI: 10.3390/encyclopedia2020063] [Reference Citation Analysis]
5 Abo El-enin HA, Elkomy MH, Naguib IA, Ahmed MF, Alsaidan OA, Alsalahat I, Ghoneim MM, Eid HM. Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route. Pharmaceuticals 2022;15:281. [DOI: 10.3390/ph15030281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
6 Maulvi FA, Soni PD, Patel PJ, Desai AR, Desai DT, Shukla MR, Shah SA, Shah DO, Willcox MDP. Controlled bimatoprost release from graphene oxide laden contact lenses: In vitro and in vivo studies. Colloids Surf B Biointerfaces 2021;208:112096. [PMID: 34530331 DOI: 10.1016/j.colsurfb.2021.112096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Emad NA, Ahmed B, Alhalmi A, Alzobaidi N, Al-kubati SS. Recent progress in nanocarriers for direct nose to brain drug delivery. Journal of Drug Delivery Science and Technology 2021;64:102642. [DOI: 10.1016/j.jddst.2021.102642] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]